loading
Goodrx Holdings Inc stock is traded at $3.43, with a volume of 610.62K. It is up +2.08% in the last 24 hours and up +1.18% over the past month. GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$3.36
Open:
$3.36
24h Volume:
610.62K
Relative Volume:
0.80
Market Cap:
$1.17B
Revenue:
$787.89M
Net Income/Loss:
$20.56M
P/E Ratio:
58.63
EPS:
0.0585
Net Cash Flow:
$96.54M
1W Performance:
+2.08%
1M Performance:
+1.18%
6M Performance:
+56.62%
1Y Performance:
-19.67%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$3.23
$3.46
52-Week Range:
Value
$1.77
$5.8099

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name
Name
Goodrx Holdings Inc
Name
Phone
(855) 268-2822
Name
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Name
Employee
697
Name
Twitter
Name
Next Earnings Date
2026-11-03
Name
Latest SEC Filings
Name
GDRX's Discussions on Twitter

Compare GDRX vs VEEV, TEM, BTSG, HNGE, HQY

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
GDRX icon
GDRX
Goodrx Holdings Inc
3.43 1.17B 787.89M 20.56M 96.54M 0.0585
VEEV icon
VEEV
Veeva Systems Inc
296.13 47.95B 3.32B 941.65M 1.64B 5.6161
TEM icon
TEM
Tempus Ai Inc
70.93 12.88B 1.36B -302.91M -219.93M -1.7182
BTSG icon
BTSG
Brightspring Health Services Inc
63.74 12.61B 13.65B 169.86M 412.12M 1.0758
HNGE icon
HNGE
Hinge Health Inc
102.90 8.30B 646.34M -512.40M 202.76M -6.6871
HQY icon
HQY
Healthequity Inc
92.61 7.66B 1.34B 230.70M 440.96M 2.6695

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-27-26 Downgrade JP Morgan Overweight → Neutral
Jan-22-26 Downgrade Jefferies Buy → Hold
Dec-09-25 Initiated Barclays Underweight
Aug-11-25 Downgrade Raymond James Strong Buy → Outperform
Dec-04-24 Initiated Mizuho Neutral
Aug-09-24 Upgrade Raymond James Outperform → Strong Buy
May-23-24 Upgrade RBC Capital Mkts Sector Perform → Outperform
May-16-24 Upgrade Raymond James Mkt Perform → Outperform
Apr-10-24 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-25-24 Upgrade Wells Fargo Equal Weight → Overweight
Mar-01-24 Upgrade JP Morgan Neutral → Overweight
Feb-26-24 Initiated Leerink Partners Outperform
Jan-02-24 Downgrade BofA Securities Buy → Underperform
Aug-10-23 Upgrade DA Davidson Neutral → Buy
Jul-31-23 Upgrade TD Cowen Market Perform → Outperform
Dec-01-22 Initiated Citigroup Buy
Nov-04-22 Upgrade JP Morgan Underweight → Neutral
Sep-16-22 Initiated KeyBanc Capital Markets Sector Weight
Sep-07-22 Initiated Truist Hold
Aug-12-22 Initiated DA Davidson Neutral
Jun-10-22 Downgrade Goldman Buy → Neutral
Jun-06-22 Resumed BofA Securities Buy
Jun-01-22 Downgrade Robert W. Baird Outperform → Neutral
May-10-22 Downgrade Evercore ISI Outperform → In-line
May-10-22 Downgrade RBC Capital Mkts Outperform → Sector Perform
May-10-22 Downgrade Raymond James Outperform → Mkt Perform
May-10-22 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-11-22 Initiated Wells Fargo Equal Weight
Apr-07-22 Initiated Guggenheim Buy
Apr-01-22 Resumed Credit Suisse Neutral
Mar-15-22 Upgrade Robert W. Baird Neutral → Outperform
Mar-01-22 Reiterated Barclays Overweight
Mar-01-22 Reiterated BofA Securities Neutral
Mar-01-22 Downgrade Cowen Outperform → Market Perform
Mar-01-22 Downgrade Credit Suisse Outperform → Neutral
Mar-01-22 Reiterated Evercore ISI Outperform
Mar-01-22 Reiterated Goldman Buy
Mar-01-22 Reiterated JP Morgan Underweight
Mar-01-22 Reiterated RBC Capital Mkts Outperform
Mar-01-22 Reiterated SVB Leerink Outperform
Jan-07-22 Initiated Goldman Buy
Dec-21-21 Initiated Stephens Overweight
Dec-02-21 Initiated Jefferies Buy
Aug-31-21 Upgrade Barclays Equal Weight → Overweight
Aug-13-21 Upgrade Raymond James Mkt Perform → Outperform
May-28-21 Initiated Robert W. Baird Neutral
Apr-06-21 Resumed Evercore ISI Outperform
Jan-25-21 Initiated Guggenheim Buy
Nov-19-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-18-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-19-20 Initiated Barclays Equal Weight
Oct-19-20 Initiated BofA Securities Neutral
Oct-19-20 Initiated Citigroup Buy
Oct-19-20 Initiated Cowen Outperform
Oct-19-20 Initiated Credit Suisse Outperform
Oct-19-20 Initiated Deutsche Bank Hold
Oct-19-20 Initiated Goldman Neutral
Oct-19-20 Initiated JP Morgan Neutral
Oct-19-20 Initiated Morgan Stanley Overweight
Oct-19-20 Initiated RBC Capital Mkts Sector Perform
Oct-19-20 Initiated SVB Leerink Outperform
Oct-19-20 Initiated UBS Buy
View All

Goodrx Holdings Inc Stock (GDRX) Latest News

pulisher
Oct 06, 2026

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors - Lelezard

Oct 06, 2026
pulisher
Sep 25, 2026

GoodRx Holdings (NasdaqGS:GDRX) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 25, 2026
pulisher
Sep 15, 2026

GoodRx CFO Justin Fengler Reports RSU Vesting and Share Withholding on September 15, 2026 - Kalkine Media

Sep 15, 2026
pulisher
Sep 15, 2026

GoodRx CAO Thomas Chan Reports RSU Vesting and Tax-Related Share Withholding on September 15, 2026 - Kalkine Media

Sep 15, 2026
pulisher
Sep 15, 2026

GoodRx (GDRX) exec converts RSUs and withholds shares for taxes - Stock Titan

Sep 15, 2026
pulisher
Sep 09, 2026

GoodRX’s $32 Million Data-Sharing Settlement Wins Initial Nod - Bloomberg Law News

Sep 09, 2026
pulisher
Sep 09, 2026

AIAI Stock Price, Quote & News - Syfe

Sep 09, 2026
pulisher
Sep 07, 2026

TaskUs, Inc. Class A (TASK) Stock Price & News - Syfe

Sep 07, 2026
pulisher
Sep 06, 2026

InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - Investing.com Australia

Sep 06, 2026
pulisher
Sep 06, 2026

InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - investing.com

Sep 06, 2026
pulisher
Sep 03, 2026

GoodRx offers health subscription for families, to launch as employee benefit in 2027 - reuters.com

Sep 03, 2026
pulisher
Sep 03, 2026

GDRX Looks 34.8% Undervalued on GF Value™ - GuruFocus

Sep 03, 2026
pulisher
Sep 03, 2026

One plan covers kids, adults and pets. GoodRx's new membership costs $24.99 a month. - Stock Titan

Sep 03, 2026
pulisher
Aug 31, 2026

Promising Penny Stocks To Consider In August 2026 - simplywall.st

Aug 31, 2026
pulisher
Aug 27, 2026

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX) - The Globe and Mail

Aug 27, 2026
pulisher
Aug 27, 2026

GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com Nigeria

Aug 27, 2026
pulisher
Aug 26, 2026

GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com India

Aug 26, 2026
pulisher
Aug 26, 2026

Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale - Stock Titan

Aug 26, 2026
pulisher
Aug 26, 2026

GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com

Aug 26, 2026
pulisher
Aug 24, 2026

GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Moomoo

Aug 24, 2026
pulisher
Aug 24, 2026

GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Quiver Quantitative

Aug 24, 2026
pulisher
Aug 23, 2026

GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingROE Trend Analysis - vinanet.vn

Aug 23, 2026
pulisher
Aug 23, 2026

GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingProfit Announcement - vinanet.vn

Aug 23, 2026
pulisher
Aug 22, 2026

GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com Australia

Aug 22, 2026
pulisher
Aug 22, 2026

GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com India

Aug 22, 2026
pulisher
Aug 21, 2026

GDRX Maintains Underweight Rating -- Price Target Raised to $4.0 - GuruFocus

Aug 21, 2026
pulisher
Aug 21, 2026

Q2 2026 GoodRx Holdings, Inc. Earnings Call Transcript - GuruFocus

Aug 21, 2026
pulisher
Aug 21, 2026

GoodRx 10% owner Francisco Partners sells $4.2m in shares - Investing.com

Aug 21, 2026
pulisher
Aug 21, 2026

GoodRx(GDRX.US) 10% Shareholder Sells US$4.2 Million in Common Stock - Moomoo

Aug 21, 2026
pulisher
Aug 20, 2026

Justin Fengler Net Worth (2026) - GuruFocus

Aug 20, 2026
pulisher
Aug 19, 2026

Big GoodRx (NASDAQ: GDRX) backer prepares share sale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn

Aug 18, 2026
pulisher
Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn

Aug 18, 2026
pulisher
Aug 18, 2026

GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move: Shares Move Lower 1.88% in Latest TradingShare Repurchase Impact - siam.in

Aug 18, 2026
pulisher
Aug 17, 2026

GoodRx Holdings Inc (GDRX) (Q2 2026) Earnings Call Highlights: R - GuruFocus

Aug 17, 2026
pulisher
Aug 15, 2026

GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen - MarketBeat

Aug 15, 2026
pulisher
Aug 14, 2026

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - Yahoo Finance

Aug 14, 2026
pulisher
Aug 14, 2026

GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Aug 14, 2026
pulisher
Aug 13, 2026

GDRX Maintained by UBS -- Price Target Raised to $3.75 - GuruFocus

Aug 13, 2026
pulisher
Aug 13, 2026

GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook - Yahoo Finance

Aug 13, 2026
pulisher
Aug 13, 2026

GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise - Yahoo Finance

Aug 13, 2026
pulisher
Aug 13, 2026

GoodRx (GDRX) Stock Trades At A Premium On Earnings Despite Weak Returns - webull.com

Aug 13, 2026
pulisher
Aug 12, 2026

GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Motley Fool

Aug 12, 2026
pulisher
Aug 12, 2026

GoodRx (GDRX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 12, 2026
pulisher
Aug 12, 2026

GoodRx (NASDAQ:GDRX) Trading Down 5.1%What's Next? - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope (NASDAQ:GDRX) - Seeking Alpha

Aug 12, 2026
pulisher
Aug 12, 2026

GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 12, 2026
pulisher
Aug 11, 2026

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - The Globe and Mail

Aug 11, 2026
pulisher
Aug 11, 2026

GDRX Maintained by Citigroup -- Price Target Raised to $5.00 - GuruFocus

Aug 11, 2026

Goodrx Holdings Inc Stock (GDRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Goodrx Holdings Inc Stock (GDRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
FRANCISCO PARTNERS IV, L.P.
10% Owner
Aug 25 '26
Sale
3.44
127,273
438,443
643,466
FRANCISCO PARTNERS IV, L.P.
10% Owner
Aug 24 '26
Sale
3.46
143,594
497,122
706,649
FRANCISCO PARTNERS IV, L.P.
10% Owner
Aug 21 '26
Sale
3.50
274,717
960,630
777,213
FRANCISCO PARTNERS IV, L.P.
10% Owner
Aug 20 '26
Sale
3.52
447,259
1,574,575
913,592
Francisco Partners GP IV, L.P.
10% Owner
Aug 19 '26
Proposed Sale
3.72
2,760,995
10,270,901
0
FRANCISCO PARTNERS IV, L.P.
10% Owner
Aug 19 '26
Sale
3.53
471,975
1,666,025
1,127,436
IAN THORNTON CLARK
Director
May 13 '26
Proposed Sale
2.59
43,100
111,620
0
REY-GIRAUD AGNES
Director
Mar 12 '26
Option Exercise
0.47
192,185
90,327
277,633
Spectrum Equity VII, L.P.
10% Owner
Oct 15 '25
Sale
4.00
23,771
95,103
0
Spectrum VII Co-Investment Fun
Affiliate
Oct 15 '25
Proposed Sale
4.02
8,569
34,447
0
$5.77
price up icon 4.15%
$21.55
price up icon 3.51%
$33.13
price up icon 2.03%
$9.13
price up icon 5.67%
$35.82
price up icon 2.84%
PHR PHR
$10.81
price up icon 1.41%
Cap:     |  Volume (24h):